105 followers
RT @cpontesg: Our trial "Non-inferiority of dose reduction versus standard dosing of TNF-inhibitors in axial spondyloarthritis" is finally…
RT @cpontesg: Our trial "Non-inferiority of dose reduction versus standard dosing of TNF-inhibitors in axial spondyloarthritis" is finally…
RT @cpontesg: Our trial "Non-inferiority of dose reduction versus standard dosing of TNF-inhibitors in axial spondyloarthritis" is finally…
Our trial "Non-inferiority of dose reduction versus standard dosing of TNF-inhibitors in axial spondyloarthritis" is finally published, open access at: https://t.co/Yq8Pj0xNti